| SF-6D health preference scores | Compare to general population sample | Compare to subjects without complications | Decrements of specific complicationsa | ||
---|---|---|---|---|---|---|
 | Mean ± SD | P value | P value | Estimated coefficients | 95% CI | P value |
General healthy population (N = 220) | 0.863 ± 0.102 | NA | NA |  |  |  |
Without diabetic complication (N = 757) | 0.882 ± 0.102 | 0.025 | NA |  |  |  |
Individual complications | Â | Â | Â | Â | Â | Â |
 Heart Diseases (N = 113) | 0.834 ± 0.131 | 0.029 | <0.001 | −0.017 | (−0.042,0.008) | 0.190 |
 Stroke (N = 72) | 0.822 ± 0.150 | 0.01 | <0.001 | −0.042 | (−0.072,-0.012) | 0.005 |
 Nephropathy (N = 233) | 0.858 ± 0.117 | 0.029 | <0.001 | −0.011 | (−0.029,0.006) | 0.194 |
 ESRD (N = 75) | 0.820 ± 0.122 | 0.003 | <0.001 | −0.055 | (−0.093,-0.017) | 0.004 |
 NPDR/pre-PDR (N = 114) | 0.865 ± 0.124 | 0.881 | 0.139 | 0.004 | (−0.024,0.032) | 0.769 |
 STDR (N = 66) | 0.828 ± 0.130 | 0.023 | <0.001 | −0.043 | (−0.075,-0.010) | 0.010 |